Marketing-authorisation holder
Braintree
3 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
3 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| AXID15MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Solution | Nizatidine | United States | Not marketed | 2004 |
| HALFLYTELY5MG,N/A; 3350 N/A,210GM; 0.74GM; 2.86GM; 5.6GM | 5MG,N/A; 3350 N/A,210GM; 0.74GM; 2.86GM; 5.6GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · For solution, tablet, delayed release | Bisacodyl, N/a, Macrogol, Bicarbonate n/a,2.86gm, N/a,20mg **federal register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | United States | Not marketed | 2004 |
| MIRALAX3350 17gm/packet | 3350 17gm/scoopful · For solution | Macrogol | United States | Marketed | 1999 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States |
At a glance
- Type
- Marketing-authorisation holder
- Medicines
- 3
- Countries
- 1
- Roles
- Authorisation holder
Work with Prognia
Keep Braintree’s medicines accurate on Prognia, see how professionals use them and answer what they ask. A 20-minute call, in English.
Book a call